Because clinical trials are conducted under widely varying conditions, Cubicin (daptomycin) side effects rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.
Cubicin side effects include:
Gastrointestinal disorders
General disorders
Nervous system disorders
Skin/subcutaneous disorders
Diagnostic investigations
Infections
Vascular disorders
Renal/urinary disorders
Blood/lymphatic disorders
Respiratory disorders
Musculoskeletal disorders